NEWS

April 22, 2021

Mesoblast braces for class action on drug disclosure

MELBOURNE: A law firm in Australia is preparing a fresh class action claim ... read more

April 22, 2021

Aegros set to move on to CSL’s plasma turf

MELBOURNE: It’s been a 30-plus year journey for small plasma fractionation biotech Aegros, ... read more

April 22, 2021

Emyria shares drop after placement at 17.5 cents each

PERTH: Shares in cannabis drug developer Emyria are down 2.6 per cent for ... read more

April 22, 2021

Priceline operator API reports 30% drop in profit

MELBOURNE: Priceline operator Australian Pharmaceutical Industries is hopeful about the future of its ... read more